Run-in phase (optional)
The optional run-in phase starts immediately after organ transplantation surgery. During this phase, LTx recipients can be screened for inclusion in the EnGraft Study and may receive immunosuppression and concomitant medication as per local standard practice.The following procedures will take place:Signed informed consentEvaluation of patient eligibility including, if applicable, pregnancy testMeasurement of tacrolimus trough levels (if patient treated with an oral formulation of immediate-release tacrolimus)Testing for donor-specific antibodies (if per local practice)